3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Carcinoma, Hepatocellular
6
Drug-Related Side Effects and Adverse Reactions
2
Colorectal Neoplasms
2
Advanced Gastric Cancer
2
Uterine Cervical Neoplasms
1
Stomach Neoplasms
1
Solid Tumor
1
Small Cell Lung Carcinoma
1
Quality of Life
1
Peritoneal Metastases From Gastric Cancer
1
Ovarian Cancer Recurrent
1
Osteosarcoma
1
Meningioma
1
Immune Checkpoint Inhibition
1
Gastrointestinal Stromal Tumors
1
Esophageal Neoplasms
1
Chondrosarcoma
1
Cholangiocarcinoma
1
Carcinoma, Non-Small-Cell Lung
1
Advanced Gastric Adenocarcinoma
1
Interventions
regorafenib
1
apatinib
1
Standard of Care
1
Proton Therapy
1
Pentetic Acid
1
Palliative Care
1
Nutritional Support
1
Minocycline
1
IPI-926
1
Heparin
1
Glutamine
1
Gelclair
1
Celecoxib
1
Analgesia
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Chondrosarcoma
×
apatinib
×
Clear all
NCT04260113
2021-01-05
AIAC
Peking University People's Hospital
Phase NA
Completed
40 enrolled